Liminal Biosciences Inc is a clinical stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using our drug discovery platform and a data driven approach.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Bruce Pritchard1994
(há 30 anos)
2019
(5 years ago)
NASDAQ
Listagem
Belleville
Sede • ON43
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LMNLSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.